CYBN:CC News and Press, CYBIN INC. From 03/23/22

The American Hospital Association (AHA) is urging the Senate Finance Committee to strengthen financial support programs that assist healthcare systems to address the shortage of providers of behavioral healthcare. The organization recently penned a statement to Congress highlighting how ...

Last week, legislators in Washington State advanced a budget measure to the state’s governor. This measure includes a proposal to allocate $200,000 in funding to be used to support the Psilocybin Wellness Workgroup to study the possible legalization of psilocybin services in the sta...

Cybin (NYSE American: CYBN) (NEO: CYBN) , a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, recently received its first official issued patent. The U.S. Patent and Trademark Office (“USPTO ...

A new study has found that individuals who have been diagnosed with mental health conditions such as schizoaffective disorder, bipolar disorder or schizophrenia have a heightened risk of cardiovascular disease when they are young, in comparison to adults who haven’t been diagnosed w...

More than 60% of American who suffer from mental health conditions want access to psychedelic options Growing number of cities, states looking at decriminalizing use of psychedelic medicine Cybin is working with world-class partners, internationally recognized scientists to create saf...

Cybin (NEO: CYBN) (NYSE American: CYBN ), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM) is planning to participate in the 2022 Virtual Growth Conference. The conference is slated for March 28–30, 2022, from 9 a.m. to 5 p.m. ET. Cybin CEO Dou...

Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) (“ Cybin ” or the “ Company ”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™” is pleased to announce that Doug Drysdale, Cybin’s Chie...

Zebrafish share about 70% of the same genes with humans and roughly 85% of human genes known to be linked to human diseases. This makes them a unique model animal for biomedical research, in addition to being social, which makes them suitable for behavioral research into drug discovery a...

A recently conducted analysis of various studies has found that the rates of treatment for major depressive disorder are still low across the globe , especially for individuals living in lower-middle income and low-income countries. These findings were published in “PLOS Medicine...

Negative body image usually causes anxiety and depression, and in most people, it can also cause eating disorders and body dysmorphia to develop. Figures from the National Association of Anorexia Nervosa and Associated Disorders show that about 9% of the global population suffers from eati...